SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-19-000236
Filing Date
2019-10-15
Accepted
2019-10-15 08:03:04
Documents
14
Period of Report
2019-10-15
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K form8-kinvestorday.htm   iXBRL 8-K 45076
  Complete submission text file 0001595585-19-000236.txt   197390

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20191015.xsd EX-101.SCH 4817
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20191015_cal.xml EX-101.CAL 618
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20191015_def.xml EX-101.DEF 1468
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20191015_lab.xml EX-101.LAB 28681
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20191015_pre.xml EX-101.PRE 14738
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-kinvestorday_htm.xml XML 4548
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 191149260
SIC: 2834 Pharmaceutical Preparations